START-GAP1/DLC1 is localized in focal adhesions through interaction with the PTB domain of tensin2

Advances in Enzyme Regulation

Volumn 50, Issue 1, 2010, Pages 202-215

  Kawai, Katsuhisa ^a,b   Kitamura, Shin ya ^a   Maehira, Koji ^a   Seike, Jun ichi ^a   Yagisawa, Hitoshi ^a  

^a UNIVERSITY OF HYOGO   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN; CADHERIN; DLC1 (DELETED IN LIVER CANCER) PROTEIN, HUMAN; DLC1 (DELETED IN LIVER CANCER) PROTEIN, RAT; EPIDERMAL GROWTH FACTOR; FAT3 PROTEIN, HUMAN; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; HYBRID PROTEIN; ISOPROTEIN; PHOSPHATASE; TENC1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; FOCAL ADHESION; GENETICS; HELA CELL; HUMAN; METABOLISM; MOLECULAR GENETICS; MOUSE; PROTEIN TERTIARY STRUCTURE; RAT; SEQUENCE ALIGNMENT;

AMINO ACID SEQUENCE; ANIMALS; CADHERINS; EPIDERMAL GROWTH FACTOR; FOCAL ADHESIONS; GTPASE-ACTIVATING PROTEINS; HELA CELLS; HUMANS; MICE; MICROFILAMENT PROTEINS; MOLECULAR SEQUENCE DATA; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RATS; RECOMBINANT FUSION PROTEINS; SEQUENCE ALIGNMENT; TUMOR SUPPRESSOR PROTEINS;

EID: 77955294043     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.advenzreg.2009.10.013     Document Type: Article

References (34)

1. Alpy F., Tomasetto C. Give lipids a START: the StAR-related lipid transfer (START) domain in mammals. J Cell Sci 2005, 118:2791-2801.
2. Borg J.P., Ooi J., Levy E., Margolis B. The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol Cell Biol 1996, 16:6229-6241.
3. Calderwood D.A., Fujioka Y., de Pereda J.M., Garcia-Alvarez B., Nakamoto T., Margolis B., et al. Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling. Proc Natl Acad Sci U S A 2003, 100:2272-2277.
4. Chan L.K., Ko F.C., Ng I.O., Yam J.W. Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for tensin2 PTB domain interaction and is required for tumor-suppressive function. PLoS One 2009, 4:e5572.
5. Chien C.T., Wang S., Rothenberg M., Jan L.Y., Jan Y.N. Numb-associated kinase interacts with the phosphotyrosine binding domain of Numb and antagonizes the function of Numb in vivo. Mol Cell Biol 1998, 18:598-607.
6. Ching Y.P., Wong C.M., Chan S.F., Leung T.H., Ng D.C., Jin D.Y., et al. Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma. J Biol Chem 2003, 278:10824-10830.
7. Durkin M.E., Ullmannova V., Guan M., Popescu N.C. Deleted in liver cancer 3 (DLC-3), a novel Rho GTPase-activating protein, is downregulated in cancer and inhibits tumor cell growth. Oncogene 2007, 26:4580-4589.
8. Gustafson T.A., He W., Craparo A., Schaub C.D., O'Neill T.J. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain. Mol Cell Biol 1995, 15:2500-2508.
9. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998, 279:509-514.
10. Homma Y., Emori Y. A dual functional signal mediator showing RhoGAP and phospholipase C-δ stimulating activities. EMBO J 1995, 14:286-291.
11. Kawai K., Iwamae Y., Yamaga M., Kiyota M., Ishii H., Hirata H., et al. Focal adhesion-localization of START-GAP1/DLC1 is essential for cell motility and morphology. Genes Cells 2009, 14:227-241.
12. Kawai K., Kiyota M., Seike J., Deki Y., Yagisawa H. START-GAP3/DLC3 is a GAP for RhoA and Cdc42 and is localized in focal adhesions regulating cell morphology. Biochem Biophys Res Commun 2007, 364:783-789.
13. Kawai K., Seike J.-I., Iino T., Kiyota M., Iwamae Y., Nishitani H., et al. START-GAP2/DLC2 is localized in focal adhesions via its N-terminal region. Biochem Biophys Res Commun 2009, 380:736-741.
14. Kawai K., Yamaga M., Iwamae Y., Kiyota M., Kamata H., Hirata H., et al. A PLCdelta1-binding protein, p122RhoGAP, is localized in focal adhesions. Biochem Soc Trans 2004, 32:1107-1109.
15. Liao Y.C., Si L., deVere White R.W., Lo S.H. The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1. J Cell Biol 2007, 176:43-49.
16. Lo S.H. Tensin. Int J Biochem Cell Biol 2004, 36:31-34.
17. Moon S.Y., Zheng Y. Rho GTPase-activating proteins in cell regulation. Trends Cell Biol 2003, 13:13-22.
18. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 1995, 9:484-496.
19. Olofsson B. Rho guanine dissociation inhibitors: pivotal molecules in cellular signalling. Cell Signal 1999, 11:545-554.
20. Qian X., Li G., Asmussen H.K., Asnaghi L., Vass W.C., Braverman R., et al. Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities. Proc Natl Acad Sci U S A 2007, 104:9012-9017.
21. Rebecchi M.J., Pentyala S.N. Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol Rev 2000, 80:1291-1335.
22. Ridley A.J., Paterson H.F., Johnston C.L., Diekmann D., Hall A. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 1992, 70:401-410.
23. Sekimata M., Kabuyama Y., Emori Y., Homma Y. Morphological changes and detachment of adherent cells induced by p122, a GTPase-activating protein for Rho. J Biol Chem 1999, 274:17757-17762.
24. Wong C.C., Wong C.M., Ko F.C., Chan L.K., Ching Y.P., Yam J.W., et al. Deleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinoma. PLoS One 2008, 3:e2779.
25. Wong C.M., Yam J.W., Ching Y.P., Yau T.O., Leung T.H., Jin D.Y., et al. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma. Cancer Res 2005, 65:8861-8868.
26. Yam J.W., Ko F.C., Chan C.Y., Jin D.Y., Ng I.O. Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression. Cancer Res 2006, 66:8367-8372.
27. Yamaga M., Kawai K., Kiyota M., Homma Y., Yagisawa H. Recruitment and activation of phospholipase C (PLC)-δ1 in lipid rafts by muscarinic stimulation of PC12 cells: contribution of p122RhoGAP/DLC1, a tumor-suppressing PLCδ1 binding protein. Adv Enzym Regul 2008, 48:41-54.
28. Yamaga M., Sekimata M., Fujii M., Kawai K., Kamata H., Hirata H., et al. A PLCδ1-binding protein, p122/RhoGAP, is localized in caveolin-enriched membrane domains and regulates caveolin internalization. Genes Cells 2004, 9:25-37.
29. Yan K.S., Kuti M., Zhou M.M. PTB or not PTB - that is the question. FEBS Lett 2002, 513:67-70.
30. Yuan B.Z., Miller M.J., Keck C.L., Zimonjic D.B., Thorgeirsson S.S., Popescu N.C. Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res 1998, 58:2196-2199.
31. Yuan B.Z., Zhou X., Durkin M.E., Zimonjic D.B., Gumundsdottir K., Eyfjord J.E., et al. DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity. Oncogene 2003, 22:445-450.
32. Zheng Y. Dbl family guanine nucleotide exchange factors. Trends Biochem Sci 2001, 26:724-732.
33. Zhou X., Thorgeirsson S.S., Popescu N.C. Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells. Oncogene 2004, 23:1308-1313.
34. Zwahlen C., Li S.C., Kay L.E., Pawson T., Forman-Kay J.D. Multiple modes of peptide recognition by the PTB domain of the cell fate determinant Numb. EMBO J 2000, 19:1505-1515.